Nanozymes have been designed to address the limitations of high cost and poor stability involving natural enzymes in analytical applications. However, the catalytic efficiency of the nanozyme still needs to be improved so that it can meet the selectivity and stability requirements of accurate biomolecule analysis. Here, we presented structure defects of metal−organic frameworks (MOFs) as a tuning strategy to regulate the catalytic efficiency of artificial nanozymes and investigated the roles of defects on the catalytic activity of oxidase-like MOFs. Structural defects were introduced into a novel Co-containing zeolitic imidazolate framework with gradually loosened morphology (ZIF-L-Co) by doping cysteine (Cys). It was found that with the increase in defect degree, the properties of materials such as ascorbate oxidase-like, glutathione oxidase-like, and laccase-like were obviously enhanced by over 5, 2, and 3 times, respectively. In-depth structural investigations indicate that the doping of sulfur inducing structural defects which may destroy the equilibrium state between cobalt and nitrogen in 2-methylimidazole and distort the crystal lattice, thereby enhancing the adsorption of oxygen and thus promoting the oxidase-like activity. The ZIF-L-Co-10 mg with enhanced ascorbate oxidase-and laccase-like activity was loaded into a microreactor and integrated into an online electrochemical system (OECS) in the upstream of the detector. This nanozyme-based microreactor can completely remove ascorbic acid, dopamine, and 3,4-dihydroxyphenylacetic acid which are the main interference toward uric acid (UA) electrochemical measurement, and the ZIF-L-Co-10 mg Cys-based OECS system is capable of continuously capturing UA change in rat brain following ischemia−reperfusion injury. Structure defect tuning of ZIF-L-Co not only provides a new regulatory strategy for artificial nanozyme activity but also provides a critical chemical platform for the investigation of UA-related brain function and brain diseases.

Adenosine triphosphate (ATP) is the major resource of energy supply in tumor activity. Therefore, improving ATP consumption efficiencies is a promising approach for cancer therapy. Herein, inspired by the H2O2-involved structure regulation effect during the catalysis of natural protein enzymes, we developed an artificial H2O2-driven ATP catalysis-promoting system, the Ce-based metal–organic framework (Ce-MOF), for catalytic cancer therapy. In the presence of H2O2, the hydrolysis ATP activity of Ce-MOF­(H2O2) was enhanced by around 1.6 times. Taking advantage of the endogenous H2O2 in cancerous cells, catalytic hydrolysis for intracellular ATP of the Ce-MOF achieves the inhibition of cancerous cell growth, which involves damaged mitochondrial function and autophagy-associated cell death. Furthermore, in vivo studies suggest that the Ce-MOF has a good tumor inhibition effect. The artificial H2O2-driven ATP catalysis-promoting system not only demonstrates high catalytic ATP consumption efficiencies for cancer therapy but also highlights a bioinspired strategy to expedite nanozyme research in both design and applied sciences.